Flossie Wong-Staal was a Chinese-American virologist and molecular biologist whose work helped transform HIV from a mysterious killer into a virus whose genes, variation, and weaknesses could be studied and eventually managed. She was the first scientist to clone HIV and to map the functions of its genes, contributions that strengthened the case that HIV causes AIDS and that later underpinned blood tests and combination drug therapy. Born Wong Yee Ching on 27 August 1946 in Guangzhou, China, she was the third of four children. In 1952 her family fled to Hong Kong after the Communist revolution. There she attended Maryknoll Convent School, a Catholic girls school run by American nuns. Teachers recognized her talent in science and encouraged her to take an English name. Wanting something distinctive rather than a common saint’s name, she asked her father, who chose Flossie after a typhoon that had recently struck the region.
No woman in her family had previously attended university or worked outside the home, but her parents supported her education. At eighteen she left Hong Kong for the University of California, Los Angeles. She completed a bachelor’s degree in bacteriology in three years, graduating with high honors in 1968, and earned a Ph.D. in molecular biology in 1972. During graduate school she married Stephen Staal and later had two daughters. After a brief postdoctoral period at the University of California, San Diego, she moved in 1973 to Bethesda, Maryland, to join Robert Gallo’s Laboratory of Tumor Cell Biology at the National Cancer Institute.
Gallo’s group was investigating retroviruses, then still a controversial idea as agents of human disease. Wong-Staal provided molecular evidence that human T-lymphotropic virus, or HTLV-1, could cause adult T-cell leukemia, helping establish that a human retrovirus can be carcinogenic. When AIDS appeared in the early 1980s, the same laboratory was positioned to study the new pathogen. French researchers at the Pasteur Institute isolated the virus first and published in 1983. Gallo’s team, including Wong-Staal, independently isolated related isolates and assembled the evidence that the virus, later named HIV, was the cause of AIDS.
Wong-Staal’s distinctive contribution was molecular. In the mid-1980s her group produced the first molecular clone of HIV, obtained a genetic map of the virus, and began assigning functions to its genes, including the regulatory genes tat and rev and several accessory genes. Cloning allowed the virus to be grown and manipulated in the laboratory rather than studied only from patient samples. Transfection experiments showed that cloned HIV could kill human T lymphocytes in culture, reinforcing the causal link to AIDS. She and colleagues also documented the virus’s high genetic diversity both among patients and within a single infected person. That microvariation helped explain why HIV evades the immune system and why a single drug would fail; it later supported the logic of combination “cocktail” therapy. Her work supplied molecular tools for second-generation blood tests that detected viral genetic material rather than only antibodies.
During the 1980s she co-authored more than a hundred papers with Gallo and others and became the most-cited female scientist of the decade, with nearly 7,800 citations according to contemporary analyses. In 1982 she was named chief of the Section of Molecular Genetics of Hematopoietic Cells. Colleagues described her as complementary to Gallo’s clinical intuition: precise, systematic, and able to turn messy biological material into defined clones and maps.
In 1990 she left the National Institutes of Health for the University of California, San Diego, as the Florence Seeley Riford Chair in AIDS Research. In 1994 she became director of the newly created UCSD Center for AIDS Research. There she shifted toward therapy, exploring gene therapy and ribozymes as “molecular knives” that might cut HIV RNA in stem cells and block viral replication. The center became a major site for AIDS research. After retiring from UCSD in 2002 she served as vice president and chief scientific officer of Immusol, a company she co-founded with her second husband, neurologist Jeffrey McKelvy. The firm, later renamed iTherX Pharmaceuticals, applied related antiviral strategies to hepatitis C.
Wong-Staal published more than four hundred papers over her career and trained many postdoctoral fellows who themselves became leaders. She was elected to the National Academy of Medicine and to Taiwan’s Academia Sinica in 1994. Discover magazine listed her among the fifty most important women in science in 2002. The Daily Telegraph ranked her thirty-second among living geniuses in 2007. In 2019 she was inducted into the National Women’s Hall of Fame. She was also a competitive ballroom dancer later in life.
She died on 8 July 2020 in San Diego of complications of pneumonia unrelated to COVID-19. She was seventy-three. She was survived by her husband, two daughters, grandchildren, and siblings. Her name is less famous in public memory than those of some of her male contemporaries, in part because credit for the original isolation of HIV was long contested between American and French groups. Within virology she is remembered for the work that made the virus intelligible: cloning it, charting its genes, showing its variability, and converting that knowledge into tests and the conceptual basis of modern treatment. The combination therapies that turned HIV infection from a near-certain death sentence into a chronic, manageable condition rest on that molecular foundation. She was a first-generation immigrant, the first woman in her family to take a scientific degree, and one of the central figures who met a new pandemic with the tools of molecular biology at a moment when those tools were still young.